LINC01751

Across TCGA pan-cancer cohorts, LINC01751 RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated LINC01751 data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher LINC01751 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC01751 expression acts as an unfavorable survival marker, although some lineages such as KIRC show a favorable association.

LUAD, KIRC, and THYM are the cancer types where LINC01751 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Tertile	All	0.138	0.368	<.001	81	view →
KIRC	DFS	Quartile	IV	0.711	0.326	.001	58	view →
THYM	DFS	Tertile	All	0.092	0.871	<.001	54	view →
ACC	OS	Tertile	All	0.117	0.631	.003	54	view →
CESC	DFS	Tertile	II,III,IV	0.144	0.705	.029	36	view →
PAAD	OS	Tertile	All	0.100	0.590	<.001	36	view →
SARC	DFS	Tertile	All	0.278	0.611	<.001	36	view →
PCPG	DFS	Tertile	All	0.047	0.946	<.001	18	view →
KIRP	DFS	Quartile	IV	0.042	0.619	.008	16	view →
SKCM	OS	Tertile	All	0.434	0.783	.028	9	view →
LGG	DFS	Tertile	All	0.701	0.838	.011	9	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

LINC01751–LUAD (OS)

Open the LUAD breakdown →